Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 28623U101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 2
|
0% |
8/14/2025
Event 7/23/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 0% | ||
| FHMLSP, L.P. | 0% | ||
| FHMLSP, L.L.C. | 0% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 0% | ||
| FHMLSP Overage, L.P. | 0% | ||
| FHMLSP Overage, L.L.C. | 0% | ||
| Frazier Life Sciences X, L.P. | 0% | ||
| FHMLS X, L.P. | 0% | ||
| FHMLS X, L.L.C. | 0% | ||
| Frazier Life Sciences XI, L.P. | 0% | ||
| FHMLS XI, L.P. | 0% | ||
| FHMLS XI, L.L.C. | 0% | ||
| James N. Topper | 0% | ||
| Patrick J. Heron | 0% | ||
| Albert Cha | 0% | ||
| James Brush | 0% | ||
| Daniel Estes | 0% | ||
|
Tang Capital Management LLC
13G/A
Amendment 3
|
4.99% |
8/14/2025
Event 6/30/2025
|
|
| Tang Capital Management, LLC | 4.99% | ||
| Kevin Tang | 4.99% | ||
| Tang Capital Partners, LP | 4.99% | ||
| Tang Capital Partners International, LP | 0% | ||
| Tang Capital Partners III, Inc | 0% | ||
| Tang Capital Partners IV, Inc | 0% | ||
| BML Investment Partners, L.P. 13D/A Amendment 1 | 0% |
7/28/2025
Event 7/23/2025
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 0.6% |
7/17/2025
Event 6/30/2025
|
|
|
Tang Capital Management LLC
13G/A
Amendment 2
|
10.0% |
5/15/2025
Event 3/31/2025
|
|
| Tang Capital Management, LLC | 10.0% | ||
| Kevin Tang | 10.0% | ||
| Tang Capital Partners, LP | 8.4% | ||
| Tang Capital Partners International, LP | 0.9% | ||
| Tang Capital Partners III, Inc | 0.7% | ||
| Tang Capital Partners IV, Inc | 0% | ||
|
Biotechnology Value Fund L P
13G/A
Amendment 4
|
7.0% |
5/15/2025
Event 3/31/2025
|
|
| Biotechnology Value Fund L P | 3.9% | ||
| BVF I GP LLC | 3.9% | ||
| Biotechnology Value Fund II LP | 3.0% | ||
| BVF II GP LLC | 3.0% | ||
| Biotechnology Value Trading Fund OS LP | 0.4% | ||
| BVF Partners OS Ltd. | 0.4% | ||
| BVF GP Holdings LLC | 6.6% | ||
| BVF Partners L P/IL | 7.0% | ||
| BVF Inc/IL | 7.0% | ||
| Lampert Mark N | 7.0% | ||
|
Farallon Capital Partners, L.P.
13G/A
Amendment 3
|
0% |
5/7/2025
Event 3/31/2025
|
|
| Farallon Capital Partners, L.P. | 0% | ||
| Farallon Capital Institutional Partners, L.P. | 0% | ||
| Farallon Capital Institutional Partners II, L.P. | 0% | ||
| Farallon Capital Institutional Partners III, L.P. | 0% | ||
| Four Crossings Institutional Partners V, L.P. | 0% | ||
| Farallon Capital Offshore Investors II, L.P. | 0% | ||
| Farallon Capital F5 Master I, L.P. | 0% | ||
| Farallon Capital (AM) Investors, L.P. | 0% | ||
| Farallon Partners, L.L.C. | 0% | ||
| Farallon Institutional (GP) V, L.L.C. | 0% | ||
| Farallon F5 (GP), L.L.C. | 0% | ||
| Dapice Joshua J. | 0% | ||
| Dreyfuss, Philip D. | 0% | ||
| Dunn Hannah E. | 0% | ||
| Fried, Richard B | 0% | ||
| Gehani, Varun N. | 0% | ||
| Giauque, Nicolas | 0% | ||
| Kim, David T. | 0% | ||
| Linn, Michael G. | 0% | ||
| Luo Patrick (Cheng) | 0% | ||
| Patel, Rajiv A. | 0% | ||
| Roberts, Jr., Thomas G. | 0% | ||
| Saito Edric C. | 0% | ||
| Seybold, William | 0% | ||
| Short Daniel S. | 0% | ||
| Spokes, Andrew J. M. | 0% | ||
| Warren, John R. | 0% | ||
| Wehrly, Mark C. | 0% | ||
| BML Investment Partners, L.P. 13D | 9.9% |
4/16/2025
Event 4/16/2025
|
|
| BML Investment Partners, L.P. 13G | 9.9% |
3/26/2025
Event 3/21/2025
|
|
|
Logos Global Management LP
13G/A
Amendment 2
|
0% |
2/14/2025
Event 12/31/2024
|
|
| Logos Global Management LP | 0% | ||
| Logos Global Master Fund LP | 0% | ||
| Logos GP LLC | 0% | ||
| Arsani William | 0% | ||
| Logos Global Management GP LLC | 0% | ||
|
Goldman Sachs Group Inc
13G/A
Amendment 1
|
2.8% |
2/6/2025
Event 12/31/2024
|
|
| The Goldman Sachs Group, Inc. | 2.8% | ||
| Goldman Sachs & Co. LLC | 2.8% | ||
|
Farallon Capital Partners, L.P.
13G/A
Amendment 2
|
6.0% |
2/5/2025
Event 12/31/2024
|
|
| Farallon Capital Partners, L.P. | 1.2% | ||
| Farallon Capital Institutional Partners, L.P. | 1.1% | ||
| Farallon Capital Institutional Partners II, L.P. | 0.3% | ||
| Farallon Capital Institutional Partners III, L.P. | 0.1% | ||
| Four Crossings Institutional Partners V, L.P. | 0.2% | ||
| Farallon Capital Offshore Investors II, L.P. | 2.1% | ||
| Farallon Capital F5 Master I, L.P. | 0.7% | ||
| Farallon Capital (AM) Investors, L.P. | 0.1% | ||
| Farallon Partners, L.L.C. | 5.3% | ||
| Farallon Institutional (GP) V, L.L.C. | 0.2% | ||
| Farallon F5 (GP), L.L.C. | 0.7% | ||
| Dapice Joshua J. | 6.0% | ||
| Dreyfuss, Philip D. | 6.0% | ||
| Dunn Hannah E. | 6.0% | ||
| Fried, Richard B | 6.0% | ||
| Gehani, Varun N. | 6.0% | ||
| Giauque, Nicolas | 6.0% | ||
| Kim, David T. | 6.0% | ||
| Linn, Michael G. | 6.0% | ||
| Luo Patrick (Cheng) | 6.0% | ||
| Patel, Rajiv A. | 6.0% | ||
| Roberts, Jr., Thomas G. | 6.0% | ||
| Saito Edric C. | 6.0% | ||
| Seybold, William | 6.0% | ||
| Short Daniel S. | 6.0% | ||
| Spokes, Andrew J. M. | 6.0% | ||
| Warren, John R. | 6.0% | ||
| Wehrly, Mark C. | 6.0% | ||
| BlackRock, Inc. 13G | 5.4% |
2/4/2025
Event 12/31/2024
|
|
| Vanguard Group Inc 13G/A Amendment 2 | 4.4% |
1/30/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q3 | 1 | 2.00 k | $720.00 |
| 2025 Q2 | 68 | 29.5 M | $10.8 M |
| 2025 Q1 | 75 | 33.8 M | $8.76 M |
| 2024 Q4 | 74 | 40.0 M | $22.5 M |
| 2024 Q3 | 72 | 46.0 M | $27.6 M |
| 2024 Q2 | 87 | 57.3 M | $154 M |
| 2024 Q1 | 68 | 44.2 M | $227 M |
| 2023 Q4 | 35 | 25.9 M | $13.9 M |
| 2023 Q3 | 43 | 28.6 M | $18.9 M |
| 2023 Q2 | 41 | 31.5 M | $48.8 M |
| 2023 Q1 | 28 | 16.2 M | $30.9 M |
| 2022 Q4 | 29 | 14.4 M | $13.7 M |
| 2022 Q3 | 26 | 14.3 M | $16.1 M |
| 2022 Q2 | 28 | 15.4 M | $21.5 M |
| 2022 Q1 | 32 | 18.7 M | $47.2 M |
| 2021 Q4 | 37 | 18.3 M | $110 M |
| 2021 Q3 | 23 | 15.9 M | $123 M |
| 2021 Q2 | 37 | 16.2 M | $217 M |